FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev...

ATLANTA, USA, (CDC News) – US Centers for Disease Control and Prevention (CDC) Director Mandy Cohen recommends second dose of 2024-2025 COVID-19...

The party of “Science” apparently misled hundreds of millions of people on the actual science surrounding the Covid-19 pandemic. Stop the...

Last week I saw a somewhat shabbily dressed man in the pharmacy trying to get a Covid booster. They told him it would cost $130. (It was the Moderna...

THURSDAY, Oct. 31, 2024 -- Don’t automatically throw out that old COVID-19 at-home test you just came across in your medicine cabinet. It might...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year.

Starting Nov. 4, doses of the RSV immunization will also be available for infants and high-risk children up to 24 months

RSV immunizations available November 4, expanded program will protect more infants and high risk children Starting Monday, October 28, 2024, Ontarians...

Press Release November 1, 2024 The Department of Health is reminding Nunavummiut that viral respiratory infections are expected to increase as...

RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE) October 28, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada,...